MARX Biotech Co., Ltd. (7731.TWO) stock: key figures, P/E, revenue and dividend
Health Care · Taiwan · ISIN TW0007731002
Price
4.16 TWD
Market cap
2.17 bn TWD
P/E (2025)
50.59
P/S (2025)
3.42
Dividend yield
1.38 %
Net margin
6.75 %
Return on equity (ROE)
11.94 %
Return on assets (ROA)
5.15 %
MARX Biotech Co., Ltd. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 618.23 m TWD | 635.85 m TWD |
| Gross profit | 430.07 m TWD | 394.59 m TWD |
| Operating income | -77.39 m TWD | -139.46 m TWD |
| EBIT | -95.22 m TWD | 71.47 m TWD |
| Net income | -96.83 m TWD | 42.92 m TWD |
| Diluted EPS – continuing operations | -0.19 TWD | 0.08 TWD |
Full history since 2021, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About MARX Biotech Co., Ltd.
MARX Biotech Co., Ltd. engages in the online retail of men's health food and cosmeceutical products. The company was founded in 2015 and is based in New Taipei City, Taiwan.
More stocks
- Lumir Inc. (474170.KQ)
- Panram International (8088.TWO)
- Genexine Inc (095700.KQ)
- 3s Silicon Tech., Inc. (5297.TWO)
- Gseven Co Ltd (2937.TWO)
- Redwood Capital Bancorp (RWCB)
- Nevgold Corp. (NAU.V)
- Milestone Pharmaceuticals Inc. (MIST)
- Fatpipe Inc/UT (FATN)
- AIAI Holdings Corporation Class A Common Stock (AIAI)
- COGNITION THERAPEUTICS INC (CGTX)
- Ilyda SA (ILYDA.AT)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.